C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.

Apolipoprotein L-I (apoL1) is a human-specific serum protein that kills Trypanosoma brucei through ionic pore formation in endosomal membranes of the parasite. The T. brucei subspecies rhodesiense and gambiense resist this lytic activity and can infect humans, causing sleeping sickness. In the case...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laurence Lecordier, Benoit Vanhollebeke, Philippe Poelvoorde, Patricia Tebabi, Françoise Paturiaux-Hanocq, Fabienne Andris, Laurence Lins, Etienne Pays
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
Acceso en línea:https://doaj.org/article/d66f838f76254f2295276b1865b12a8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d66f838f76254f2295276b1865b12a8f
record_format dspace
spelling oai:doaj.org-article:d66f838f76254f2295276b1865b12a8f2021-11-25T05:48:28ZC-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.1553-73661553-737410.1371/journal.ppat.1000685https://doaj.org/article/d66f838f76254f2295276b1865b12a8f2009-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19997494/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Apolipoprotein L-I (apoL1) is a human-specific serum protein that kills Trypanosoma brucei through ionic pore formation in endosomal membranes of the parasite. The T. brucei subspecies rhodesiense and gambiense resist this lytic activity and can infect humans, causing sleeping sickness. In the case of T. b. rhodesiense, resistance to lysis involves interaction of the Serum Resistance-Associated (SRA) protein with the C-terminal helix of apoL1. We undertook a mutational and deletional analysis of the C-terminal helix of apoL1 to investigate the linkage between interaction with SRA and lytic potential for different T. brucei subspecies. We confirm that the C-terminal helix is the SRA-interacting domain. Although in E. coli this domain was dispensable for ionic pore-forming activity, its interaction with SRA resulted in inhibition of this activity. Different mutations affecting the C-terminal helix reduced the interaction of apoL1 with SRA. However, mutants in the L370-L392 leucine zipper also lost in vitro trypanolytic activity. Truncating and/or mutating the C-terminal sequence of human apoL1 like that of apoL1-like sequences of Papio anubis resulted in both loss of interaction with SRA and acquired ability to efficiently kill human serum-resistant T. b. rhodesiense parasites, in vitro as well as in transgenic mice. These findings demonstrate that SRA interaction with the C-terminal helix of apoL1 inhibits its pore-forming activity and determines resistance of T. b. rhodesiense to human serum. In addition, they provide a possible explanation for the ability of Papio serum to kill T. b. rhodesiense, and offer a perspective to generate transgenic cattle resistant to both T. b. brucei and T. b. rhodesiense.Laurence LecordierBenoit VanhollebekePhilippe PoelvoordePatricia TebabiFrançoise Paturiaux-HanocqFabienne AndrisLaurence LinsEtienne PaysPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 5, Iss 12, p e1000685 (2009)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Laurence Lecordier
Benoit Vanhollebeke
Philippe Poelvoorde
Patricia Tebabi
Françoise Paturiaux-Hanocq
Fabienne Andris
Laurence Lins
Etienne Pays
C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
description Apolipoprotein L-I (apoL1) is a human-specific serum protein that kills Trypanosoma brucei through ionic pore formation in endosomal membranes of the parasite. The T. brucei subspecies rhodesiense and gambiense resist this lytic activity and can infect humans, causing sleeping sickness. In the case of T. b. rhodesiense, resistance to lysis involves interaction of the Serum Resistance-Associated (SRA) protein with the C-terminal helix of apoL1. We undertook a mutational and deletional analysis of the C-terminal helix of apoL1 to investigate the linkage between interaction with SRA and lytic potential for different T. brucei subspecies. We confirm that the C-terminal helix is the SRA-interacting domain. Although in E. coli this domain was dispensable for ionic pore-forming activity, its interaction with SRA resulted in inhibition of this activity. Different mutations affecting the C-terminal helix reduced the interaction of apoL1 with SRA. However, mutants in the L370-L392 leucine zipper also lost in vitro trypanolytic activity. Truncating and/or mutating the C-terminal sequence of human apoL1 like that of apoL1-like sequences of Papio anubis resulted in both loss of interaction with SRA and acquired ability to efficiently kill human serum-resistant T. b. rhodesiense parasites, in vitro as well as in transgenic mice. These findings demonstrate that SRA interaction with the C-terminal helix of apoL1 inhibits its pore-forming activity and determines resistance of T. b. rhodesiense to human serum. In addition, they provide a possible explanation for the ability of Papio serum to kill T. b. rhodesiense, and offer a perspective to generate transgenic cattle resistant to both T. b. brucei and T. b. rhodesiense.
format article
author Laurence Lecordier
Benoit Vanhollebeke
Philippe Poelvoorde
Patricia Tebabi
Françoise Paturiaux-Hanocq
Fabienne Andris
Laurence Lins
Etienne Pays
author_facet Laurence Lecordier
Benoit Vanhollebeke
Philippe Poelvoorde
Patricia Tebabi
Françoise Paturiaux-Hanocq
Fabienne Andris
Laurence Lins
Etienne Pays
author_sort Laurence Lecordier
title C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
title_short C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
title_full C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
title_fullStr C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
title_full_unstemmed C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
title_sort c-terminal mutants of apolipoprotein l-i efficiently kill both trypanosoma brucei brucei and trypanosoma brucei rhodesiense.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/d66f838f76254f2295276b1865b12a8f
work_keys_str_mv AT laurencelecordier cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT benoitvanhollebeke cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT philippepoelvoorde cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT patriciatebabi cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT francoisepaturiauxhanocq cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT fabienneandris cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT laurencelins cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
AT etiennepays cterminalmutantsofapolipoproteinliefficientlykillbothtrypanosomabruceibruceiandtrypanosomabruceirhodesiense
_version_ 1718414429853319168